🟢 Cabaletta Bio is trading 7.33% up today after announcing approximately $128.2 million from warrant exercises

Cabaletta Bio is trading 7.33% up now at $2.93 after announcing approximately $128.2 million in gross proceeds from common-stock warrant exercises that expired September 12, 2026.

• The proceeds strengthen the company’s cash position and appear to be driving the advance.
• Cabaletta Bio is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14, 2026.